Cushing Syndrome
Novo Nordisk has sued Eli Lilly over national advertising campaigns for the companies' competing weight loss and diabetes drugs, alleging that Lilly is misleading consumers by using older clinical trials to claim its treatments are more effective.The lawsuit, filed Tuesday in U.S
5* EMA statement on ongoing review of GLP-1 receptor agonists 7* Glucagon-Like Peptide 1 Receptor Agonists and Mental Health A Systematic Review and Meta-Analysis Additional sources: Frontiers in Psychiatry 2023: Case Report: Semaglutide-associated depression: a report of two cases
Signs include headache, racing pulse, dizziness, nausea, muscle cramps, fainting, fatigue or rapid breathing
The Danger Zones : Above 86F (30C) : Rapid protein degradation At or below 32F (0C) : Freezingmedication must be discarded 3236F (02C) : High risk of accidental freezing
This dual action typically results in greater weight loss (up to 20% vs 15%) and often fewer side effects like nausea